Page 139 - MI-2-4

Microbes & Immunity Oxidative toxicity and folate in HIV on DTG-ART

33. Dhonju K, Gautam A, Dahal A, et al. Dolutegravir- system. Prog Food Nutr Sci. 1991;15(1-2):43-60.
induced acquired sideroblastic anemia in an HIV-positive
patient: A challenging hematologic complication. Clin Case 38. Molloy AM, Scott JM. Folates and prevention of disease.
Rep. 2023;11(12):e8301. Public Health Nutr. 2001;4(2B):601-609.
doi: 10.1002/ccr3.8301 doi: 10.1079/PHN2000128
34. Kovacic P, Somanathan R. Broad overview of oxidative 39. Lewis W, Dalakas M, Biesecker GM. Mitochondrial toxicity
stress and its complications in human health. Open J Prev of antiviral drugs. Nat Med. 2003;6(3):249-255.
Med. 2013;3(1):32-41.
doi: 10.1038/nm0303-249
doi: 10.4236/ojpm.2013.31005
40. Savinelli S, Newman E, Mallon PWG. Metabolic
35. Rothenberg SP. Increasing the dietary intake of folate: Pros complications associated with use of integrase strand
and cons. Semin Hematol. 1999;36(1):65-74. transfer inhibitors (INSTI) for the treatment of HIV-1
36. Babafemi T. General HIV Medicine. Vol 1. Hyderabad: TFC infection: Focus on weight changes, lipids, glucose and bone
Press; 2004. p. 10-11. metabolism. Curr HIV/AIDS Rep. 2024;21:567-580.
37. Dhur A, Galan P, Herberg S. Folate status and the immune doi: 10.1007/s11904-024-00683-5

Volume 2 Issue 4 (2025) 131 doi: 10.36922/MI025310074